Although induction of cardiac hypertrophy is a multifaceted process, inhibition of Shp2 activity through enhanced PKA signaling represents a previously unrecognized mechanism contributing to cardiac hypertrophy. Here, PTPN11 is linked to cardiac hypertrophy.